Phathom Pharmaceuticals, Inc. Common Stock, Shares, Outstanding from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Phathom Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2025.
  • Phathom Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 71M shares, a 3.98% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)

Phathom Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 71M +2.72M +3.98% Sep 30, 2025 10-Q 2025-10-30
Q2 2025 70.1M +11.5M +19.6% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 69.6M +11.1M +19% Mar 31, 2025 10-Q 2025-05-01
Q4 2024 68.5M +10.5M +18.2% Dec 31, 2024 10-Q 2025-10-30
Q3 2024 68.3M +11.5M +20.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 58.6M +1.96M +3.46% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 58.5M +15M +34.3% Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 58M +16.5M +39.8% Dec 31, 2023 10-K 2025-03-06
Q3 2023 56.8M +15.7M +38.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 56.6M +18.3M +47.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 43.6M +5.42M +14.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 41.5M +11M +35.9% Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 41.1M +11.1M +36.9% Sep 30, 2022 10-Q/A 2022-11-09
Q2 2022 38.4M +9.19M +31.5% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 38.1M +9.27M +32.1% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 30.5M +2M +7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 30M +4.13M +15.9% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 29.2M +3.57M +13.9% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 28.9M +3.72M +14.8% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 28.5M +3.79M +15.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 25.9M +18.5M +249% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 25.6M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 25.2M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 24.7M +18M +266% Dec 31, 2019 10-K 2021-03-30
Q3 2019 7.42M Sep 30, 2019 10-Q 2019-11-25
Q4 2018 6.76M Dec 31, 2018 10-Q 2019-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.